<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM125155"><item key="AGE">not specified</item><item key="TISSUE TYPE">normal mucosa</item><item key="PHENOTYPE">not specified</item><item key="SEX">not specified</item></item></item><item><item key="GSM125155"><item key="AGE">not specified</item><item key="TISSUE TYPE">normal mucosa</item><item key="PHENOTYPE">not specified</item><item key="SEX">not specified</item></item></item><item><item key="GSM1251553"><item key="AGE">75 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Famous oncogenes such as Nkx2.1, CHST9, FGFR2, and EGFR were expressed in high ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251554"><item key="AGE">65 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Famous oncogenes such as Nkx2.1, CHST9, FGFR3, and EGFR were expressed in high ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251555"><item key="AGE">80 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Famous oncogenes such as Nkx2.1, CHST9, FGFR4, and EGFR were expressed in high ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251556"><item key="AGE">69 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Famous oncogenes such as Nkx2.1, CHST9, FGFR5, and EGFR were expressed in high ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251557"><item key="AGE">70 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Specific oncogene was not expressed in low ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251558"><item key="AGE">74 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Specific oncogene was not expressed in low ND tumors.</item><item key="SEX">female</item></item></item><item><item key="GSM1251559"><item key="AGE">66 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Specific oncogene was not expressed in low ND tumors.</item><item key="SEX">male</item></item></item><item><item key="GSM1251560"><item key="AGE">48 years old</item><item key="TISSUE TYPE">gastric cancer</item><item key="PHENOTYPE">Specific oncogene was not expressed in low ND tumors.</item><item key="SEX">male</item></item></item></item><item key="id">4704</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">We have tried to identify molecules associated with lymph node ratio expression by microarray.  Expression microarray data prioritized...</item><item key="geo_gse_id">E-GEOD-51725</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">4</item><item key="sample_count">10</item><item key="tags"><item>cancer</item><item>lymph</item><item>lymph node</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-51725_A-AFFY-44</item><item key="slug">egfr-expression-status-associated-with-lymph-node</item><item key="geo_gds_id"/><item key="name">EGFR expression status associated with lymph node ratio</item><item key="created">Sep.21, 2014</item><item key="summary">We have tried to identify molecules associated with lymph node ratio expression by microarray.  Expression microarray data prioritized gene candidates according to average expression ratio and its frequency. Among these genes, we examined particular EGFR expression by immunohistochemistry (IHC) in 167 advanced gastric cancer. We compared tumor specimens with high LNR (n=4) with those with low one (n=4) at mRNA level by Affymetrix microarray (harboring 54,675 genes) in stage III gastric cancer.  We then prioritized the expression data, and enriched genes correlated with LNR, and finally validated EGFR as such candidates in primary advanced gastric cancer who underwent standard treatment (n=167).</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-51725</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-51725/samples/</item></data></biogps>
